SymBiosis

The firm's distributed architecture uses each office as a local sourcing node. Philadelphia and Washington provide proximity to major research universities, teaching hospitals, and federal regulatory bodies like the NIH and FDA. West Coast offices in Los Angeles connect the firm to technology crossover opportunities, while New York and Greenwich serve as capital-formation hubs with access to institutional limited partners. Singapore adds an international dimension for Asian co-investors and market access.

SymBiosis has not publicly disclosed its management structure, general partners, or investment committee composition. The firm's website and public filings do not name key decision-makers. Allocators conducting due diligence on the firm will need to request this information directly, as it is not available in the public record.